Cita APA

Moon, J., Lee, S., Choi, J. W., Lee, A. R., Yoo, J. H., Moon, S., . . . Cho, M. (2021). Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. J Transl Med.

Citación estilo Chicago

Moon, Jeonghyeon, Seon-yeong Lee, Jeong Won Choi, A Ram Lee, Jin Hee Yoo, Su-Jin Moon, Sung-Hwan Park, y Mi-La Cho. "Metformin Ameliorates Scleroderma Via Inhibiting Th17 Cells and Reducing MTOR-STAT3 Signaling in Skin Fibroblasts." J Transl Med 2021.

Cita MLA

Moon, Jeonghyeon, et al. "Metformin Ameliorates Scleroderma Via Inhibiting Th17 Cells and Reducing MTOR-STAT3 Signaling in Skin Fibroblasts." J Transl Med 2021.